Fagron Past Earnings Performance

Past criteria checks 5/6

Fagron has been growing earnings at an average annual rate of 7%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 9.9% per year. Fagron's return on equity is 16.4%, and it has net margins of 9.5%.

Key information

7.0%

Earnings growth rate

6.6%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate9.9%
Return on equity16.4%
Net Margin9.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Fagron makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:FAGRB Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24821782050
31 Mar 24792741960
31 Dec 23763711870
30 Sep 23745691810
30 Jun 23727671750
31 Mar 23705691660
31 Dec 22684701580
30 Sep 22655701490
30 Jun 22626691400
31 Mar 22600651360
31 Dec 21574611330
30 Sep 21564581310
30 Jun 21554551290
31 Mar 21555571270
31 Dec 20556601250
30 Sep 20557601250
30 Jun 20558601260
31 Mar 20546581250
31 Dec 19535551250
30 Jun 19496511200
31 Mar 19484471160
31 Dec 18472431130
30 Jun 18444451030
31 Mar 18439461020
31 Dec 17434471010
30 Sep 17433161010
30 Jun 17432-141010
31 Mar 17428-151000
31 Dec 16422-19970
30 Sep 16421-25990
30 Jun 16421-311010
31 Mar 16474-2031240
31 Dec 15428-251040
30 Sep 1544181050
30 Jun 15455411060
31 Mar 15445381030
31 Dec 14447431020
30 Sep 1441846930
30 Jun 1438949840
31 Mar 1436646770
31 Dec 1334342710

Quality Earnings: FAGRB has high quality earnings.

Growing Profit Margin: FAGRB's current net profit margins (9.5%) are higher than last year (9.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FAGRB's earnings have grown by 7% per year over the past 5 years.

Accelerating Growth: FAGRB's earnings growth over the past year (15.5%) exceeds its 5-year average (7% per year).

Earnings vs Industry: FAGRB earnings growth over the past year (15.5%) exceeded the Healthcare industry 13.6%.


Return on Equity

High ROE: FAGRB's Return on Equity (16.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/19 19:13
End of Day Share Price 2024/07/22 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fagron NV is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert Jan VosABN AMRO Bank N.V.
Marc LeemansBanque Degroof
Victoria LambertBerenberg